《市評》恆指三連升 騰訊系起舞 北水轉淨流出逾82億
市場憧憬美下月減息,港股今日持續向上。美國7月通脹率維持在2.7%,低於2.8%的市場預測,美核心通脹率升至3.1%,美股道指及納指隔晚各升1.1%及1.4%,而納指與標普500指數(升1.1%)齊創收市新高。根據芝加哥商品交易所(CME)的FedWatch利率期貨工具顯示,9月減息機會96.2%(一日前機會率93.9%),撰文之時,美國2年期債券孳息跌至3.712%,美國10年期債券孳息跌至4.258%,美匯指數跌至97.72,道指期貨最新升94點或0.2%,納指期貨最新升53點或0.2%。上證綜指全日升17點或0.5%收3,683點,深證成指升1.8%,滬深兩市成交額共2.15萬億元人民幣。
港匯觸發弱方兌換保證,金管局入市買入逾70億港元。恆指高開206點後升幅擴大,以全日高位25,613點收市,升643點或2.6%,連升三日(累升754點或3%);國指全日升233點或2.6%,收9,150點;恆生科技指數升191點或3.5%,收5,630點。大市全日成交總額按日升近32%至2,840.41億元。北水交易總成交額1,537.81億元,而南向資金今日淨流出82.77億元(上日淨流入入94.5億元),自上周一(4日)(當日淨流出180.92億元)後再錄淨流出。
【恆指三連升 騰訊系受捧】
閱文(00772.HK)中期純利增68.5%獲大行唱好,全日股價升19.6%,成交13.4億元,騰訊音樂(01698.HK)次季非國際財務報告準則純利升37%勝市場預期,全日股價抽上15.6%。騰訊(00700.HK)今日收市後公布第二季業績,全日股價彈高4.7%報586元。其他科技股方面,阿里(09988.HK)升6.1%,京東(09618.HK)、美團(03690.HK)、百度(09888.HK)及快手(01024.HK)升3.8%至4.7%,嗶哩嗶哩(09626.HK)及網易(09999.HK)股價分別抽高7.4%及5.4%。
騰訊收市後公布今年第二季業績,純利達556.28億元人民幣按年增長16.8%,達到本網綜合6間券商介乎497.69億至556.14億元人民幣預測上限;每股盈利6.115元人民幣。非國際財務報告準則(Non-IFRS)下,次季淨利潤按年增長10%至630.52億人民幣,接近本網綜合11間券商介乎583.12億至653.73億元人民幣預測的上限值;Non-IFRS每股盈利6.931元人民幣。第二季收入錄1,845.04億元,按年升14.5%。按業務劃分,增值服務收入913.68億元,增長15.9%。當中國際市場遊戲收入及本土市場遊戲收入分別達到約188億及404億元,按年增長35%及17%。社交網絡收入增長6%至約322億元,主要受惠於於手遊虛擬道具銷售、視頻號直播服務收入及音樂付費會員收入的增長。
騰訊指今年第二季毛利率由去年同期的53%提升至57%,增值服務業務毛利率由去年同期的57%提升至60%,主要受本土市場遊戲所驅動,包括《三角洲行動》在內的若干自主研發遊戲的貢獻增加。公司截至今年6月底止於聯交所以總代價約365億港元購回合共8,187萬股股份(公司今年3月曾表示今年回購不低於800億元),騰訊截至今年6月底止現金淨額746億元(對比今年3月底止902.29億元),按季下降主要由於本季支付2024財政年度的末期股息375億人民幣,按騰訊2024年中期業績,其截至2024年6月底止現金淨額為717.57億元。
【升股千三隻 醫藥股舞高】
港股今日市寬續向好,主板股票的升跌比率為33比17(上日為26比23),上升股份1,371隻(升幅3.6%),恆指成份股今日79隻股份上升,下跌股5隻,升跌比率為93比6(上日65比33)。大市今日錄沽空362.05億元,佔可沽空股份成交額2,556.82億元的14.16%。
於本周一(11日)掛牌上市中慧生物-B(02627.HK)今日股價持續走強,全日再飆19.5%收52.2元,成交2.7億元,其招股的每股上市價為12.9元(周一收報33.28元,當日較上市價高158%)。
醫藥股舞高,信達生物(01801.HK)及康龍化成(03759.HK)彈升8.8%及7.8%,石藥(01093.HK)、金斯瑞(01548.HK)及藥明康德(02359.HK)升逾6%,翰森(03692.HK)、百濟神州(06160.HK)、恆瑞(01276.HK)及康希諾(06185.HK)升4.4%至5.4%。
港交所(00388.HK)本月初修訂首次公開發售(IPO)市場定價及公開市場規定,優化新股回撥機制,首隻在新制實施後招股的新股銀諾醫藥(02591.HK)昨日(12日)截止招股,根據市場消息,銀諾醫藥公開發售部分超額認購約5,364倍,有約26萬人認購,涉資約3,700億元,成為今年新股超購王第二位,僅次於超購近6,000倍的布魯可(00325.HK) 。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.